Medication Safety in Intravenous Therapy: Compatibility of Etoposide with Frequently Drugs Used in Tumour Critical Care During Simulated Y-Site Administration
Seven of the 45 common medications in tumor critical care tested with etoposide were incompatible within 4 h. If co administration is inevitable and the drug is infused through a port catheter, a larger volume of saline (NS) or dextrose 5% in water (D5W) should be used to flush the port catheter before and after the etoposide infusion to clean the lumen of the port catheter.
Authors
- Liqin Tang (ORCID: https://orcid.org/0000-0002-2972-3400)
- Sheng Liu (ORCID: https://orcid.org/0000-0002-4683-3476)
- Zhaolin Chen (ORCID: https://orcid.org/0000-0002-0173-6090)
- Haiwen Ding
- Tong Tong (ORCID: https://orcid.org/0000-0002-5614-9862)
Institutions
- University of Science and Technology of China (CN)
- Anhui Medical University (CN)
Publication Details
- Journal
- Drug Design Development and Therapy
- Published
- 2025-02-01
- DOI
- https://doi.org/10.2147/dddt.s489534
- Citations
- 1
- Primary Topic
- Neuroendocrine Tumor Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 1.35